CM
MRTX

Caption Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Caption Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,800
Closed -$752K – 1788
2023
Q4 		$752K Hold
12,800
– – 0.01% 870
2023
Q3 		$558K Hold
12,800
– – 0.01% 910
2023
Q2 		$462K Buy
+12,800
New +$527K 0.01% 839
2023
Q1 		– Sell
-203,600
Closed -$9.23M – 1685
2022
Q4 		$9.23M Sell
203,600
-76,400
-27% -$4.94M 0.14% 174
2022
Q3 		$19.6M Buy
280,000
+234,000
+509% +$17.3M 0.27% 71
2022
Q2 		$3.09M Buy
+46,000
New +$2.93M 0.04% 527
2022
Q1 		– Sell
-67,000
Closed -$9.83M – 2082
2021
Q4 		$9.83M Sell
67,000
-74,900
-53% -$11.6M 0.11% 239
2021
Q3 		$25.1M Buy
141,900
+97,800
+222% +$15.7M 0.29% 70
2021
Q2 		$7.12M Buy
44,100
+5,200
+13% +$835K 0.09% 277
2021
Q1 		$6.66M Buy
38,900
+29,900
+332% +$5.92M 0.14% 178
2020
Q4 		$1.98M Sell
9,000
-32,500
-78% -$7.03M 0.05% 438
2020
Q3 		$6.89M Buy
41,500
+16,500
+66% +$2.26M 0.16% 151
2020
Q2 		$2.85M Sell
25,000
-94,100
-79% -$9.13M 0.1% 291
2020
Q1 		$9.15M Buy
119,100
+64,100
+117% +$5.75M 0.52% 34
2019
Q4 		$7.09M Sell
55,000
-18,200
-25% -$1.76M 0.24% 101
2019
Q3 		$5.71M Buy
73,200
+62,000
+554% +$5.82M 0.3% 93
2019
Q2 		$1.15M Buy
+11,200
New +$872K 0.06% 344

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's MRTX Position: Q1 2024 in Review

Caption Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 36,600 shares — an estimated $2.15M sold.

Caption Management first reported a position in MRTX in Q1 2019 and held it in 14 quarters. The position peaked at $15.2M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Caption Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 36,600 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.15M.
  • Caption Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Caption Management's Mirati Therapeutics, Inc. Common Stock position peaked at $15.2M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.